News

Read about Samsung Biologic’s monumental decision to invest $2 billion in a “Super Plant” for biomanufacturing and pharmaceuticals.

Read our review on The Way of the Psychonaut, directed by Susan Hess Logeais, to learn about Stan Grof’s important work and influence.

Read and learn about Meet Delic’s past virtual event on how to grow a psychedelic business in this emerging industry.

Are you curious if mushrooms will follow in marijuana’s footsteps? Read to learn about how the U.S. is moving to decriminalize psilocybin.

Read about Meet Delic’s past virtual event on how ketamine serves as a therapeutic for people suffering from ‘treatment-resistant’ depression.

Researchers from the Norwegian University of Science and Technology published a population study on psychedelic use and mental health.

The Entheogenic Plant and Fungus Policy Act – Initiative 81 is on the road to decriminalizing plant medicines in D.C.

As the cannabis industry matures, it’s starting to face the same sustainability challenges as other industries. Can weed go green?

Researchers at Beaumont Hospital in Michigan perform clinical trials to explore the use of ketamine and naltrexone for treatment of COVID-19.

Johns Hopkins University School of Medicines is moving ahead with plans to conduct a ‘real world’ psychedelic study. Read here to learn more.